Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease

Por Hansson, Oskar, Hall, Sara, Öhrfelt, Annika, Zetterberg, Henrik, Blennow, Kaj, Minthon, Lennart, Nägga, Katarina, Londos, Elisabet, Varghese, Shiji, Majbour, Nour K, Al-Hayani, Abdulmonem, El-Agnaf, Omar MA
Publicado em 2014

Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human α-synuclein in transgenic mouse brain

Por Cronin, Kenneth D., Ge, Dongliang, Manninger, Paul, Linnertz, Colton, Rossoshek, Anna, Orrison, Bonnie M., Bernard, David J., El-Agnaf, Omar M.A., Schlossmacher, Michael G., Nussbaum, Robert L., Chiba-Falek, Ornit
Publicado em 2009

Development of Nonviral Vectors Targeting the Brain as a Therapeutic Approach For Parkinson's Disease and Other Brain Disorders

Por Javed, Hayate, Menon, Sindhu A, Al-Mansoori, Karima M, Al-Wandi, Abdelmojib, Majbour, Nour K, Ardah, Mustafa T, Varghese, Shiji, Vaikath, Nishant N, Haque, M Emdadul, Azzouz, Mimoun, El-Agnaf, Omar MA
Publicado no Mol Ther (2016)

α-Synuclein Levels in Blood Plasma from LRRK2 Mutation Carriers

Por Gorostidi, Ana, Bergareche, Alberto, Ruiz-Martínez, Javier, Martí-Massó, José F., Cruz, María, Varghese, Shiji, Qureshi, Mohamed M., Alzahmi, Fatimah, Al-Hayani, Abdulmonem, de Munáin, Adolfo López, El-Agnaf, Omar M.A.
Publicado em 2012

GINSENOSIDE RB1 INHIBITS FIBRILLATION AND TOXICITY OF ALPHA-SYNUCLEIN AND DISAGGREGATES PREFORMED FIBRILS

Por Ardah, Mustafa T., Paleologou, Katerina E., Lv, Guohua, Menon, Sindhu A., Khair, Salema B. Abul, Lu, Jia-Hong, Safieh-Garabedian, Bared, Al-Hayani, Abdulmonem A., Eliezer, David, Li, Min, El-Agnaf, Omar MA.
Publicado no Neurobiol Dis (2014)